4//SEC Filing
Shah Preetam 4
Accession 0001610618-22-000081
CIK 0001610618other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 8:28 PM ET
Size
12.7 KB
Accession
0001610618-22-000081
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2022-09-15−50,000→ 0 totalExp: 2022-09-30→ Common Stock (50,000 underlying) - Sale
Common Stock
2022-09-19$0.77/sh−15,642$12,035→ 150,789 total - Exercise/Conversion
Common Stock
2022-09-15+50,000→ 166,431 total
Footnotes (5)
- [F1]The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on September 15, 2022.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022.
- [F3]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 15, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F4]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- [F5]On September 1, 2021, the Reporting Person was granted restricted stock units totaling 50,000 shares subject to vesting upon the achievement of various milestones.
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001787403
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 8:28 PM ET
- Size
- 12.7 KB